Pharmacological treatment of acute decompensated heart failure (ADHF)

dc.contributor.advisorPórszász, Róbert
dc.contributor.advisordeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.authorZamanpour Siahkal, Hormoz
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentDrimba, László
dc.contributor.opponentSzentmiklósi, József András
dc.contributor.opponentdeptKenézy Kórház Központi Aneszteziológiai és Intezív Terápiás Osztályhu_HU
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.date.accessioned2019-09-26T11:32:20Z
dc.date.available2019-09-26T11:32:20Z
dc.date.created2019-05-17
dc.description.abstractHeart Failure is a worldwide pandemic affecting an expected 26 million individuals worldwide and bringing about more than 1 million hospitalizations every year in both Europe and the United States, with the expectation of an increase in the number of cases over the following 2 decades. In this text, I have tried to describe different mechanisms that explain the wide spectrum of clinical manifestations seen in acutely decompensated heart failure. I have outlined the most appropriate pharmacologic treatments and highlighted best practices for each category, according to the latest research available. I also have identified areas in which guidelines are still not available and are subject to controversy and require further research.hu_HU
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent46hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/273779
dc.language.isoenhu_HU
dc.subjectADHFhu_HU
dc.subject.dspaceDEENK Témalista::Orvostudomány::Farmakológiahu_HU
dc.titlePharmacological treatment of acute decompensated heart failure (ADHF)hu_HU
Fájlok